Gynaecological Cancer
Current Clinical Trials
Curie Research by Curie Oncology
Clinical Trial – Gynaecological Cancer
| Protocol Name / No. | Protocol Title | Principal Investigator |
|---|---|---|
| CATALINA-2 | A Phase 2 study evaluating the efficacy and safety of TORL-1-23 in Women with advanced platinum resistant epithelial ovarian cancer (including primary peritoneal and fallopian tube cancers) expressing Claudin 6 (Cldn6) NCT number: https://clinicaltrials.gov/study/NCT06690775 | Dr John Chia |
| ZWI-ZW191-101 | A Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of a Folate Receptor Alpha Antibody Drug conjugate, ZW191, in Participants with Advanced Solid Tumors NCT number: https://clinicaltrials.gov/study/NCT06555744 | Dr John Chia |
| GCT1184-03 (RAINFOL-03) | A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Investigator’s Choice (IC) in Patients with Endometrial Cancer After Platinum-Based Chemotherapy and PD(L)-1 Therapy NCT number: https://clinicaltrials.gov/study/ NCT07166094 | Dr John Chia |